Valens Semiconductor Ltd.
VLN NYSE Semiconductors & Related Devices Financials FY2019โFY2025
What Valens Semiconductor Ltd. does
No business description yet.
- Legal name
- Valens Semiconductor Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Feb 25, 2026
- Accession ยท CIK
- 0001213900-26-020108
0001863006
Revenue and margins
Valens Semiconductor Ltd. had $70.6M of revenue in fiscal 2025, up 22.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$13.8M in fiscal 2025, โ19.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Valens Semiconductor Ltd. returned $24.0M to shareholders in fiscal 2025. The diluted share count fell 2.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Valens Semiconductor Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $56.8M | $148M | $142M | $131M | $92.6M |
| Current ratio | 12.7x | 7.6x | 11.0x | 7.6x | 5.2x |
| Quick ratio | 12.1x | 6.6x | 10.1x | 7.1x | 4.7x |
| Total assets | $203M | $196M | $181M | $172M | $135M |
| Total liabilities | $20.4M | $28.2M | $16.3M | $29.5M | $29.7M |
| Shareholders' equity | $182M | $167M | $164M | $143M | $105M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | 3 / 8 | 2 / 8 | 4 / 8 | 2 / 8 | 4 / 8 |
| Accruals ratio | โ | โ0.0% | โ3.5% | โ2.8% | โ7.1% | โ21.3% | โ12.3% |
| Altman Z'' | โ | โ8.12 | 12.32 | 8.12 | 12.18 | 4.51 | 0.73 |
7 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $60.0M | $56.9M | $70.7M | $90.7M | $84.2M | $57.9M | $70.6M |
| Gross profit | $47.5M | $43.5M | $50.6M | $63.4M | $52.6M | $34.3M | $44.1M |
| Research and development | $52.7M | $44.7M | $46.9M | $58.2M | $48.2M | $40.5M | $42.7M |
| Operating income | โ$28.0M | โ$22.8M | โ$27.1M | โ$28.4M | โ$26.9M | โ$41.3M | โ$34.1M |
| Pretax income | โ$25.5M | โ$19.5M | โ$26.1M | โ$27.2M | โ$19.6M | โ$36.5M | โ$31.4M |
| Income tax | $0.4M | $0.2M | $0.4M | $0.5M | $0.1M | $0.1M | $0.2M |
| Net income | โ$25.9M | โ$19.6M | โ$26.5M | โ$27.7M | โ$19.7M | โ$36.6M | โ$31.6M |
| Net income to common | โ | โ | โ$37.9M | โ$27.7M | โ$19.7M | โ | โ |
| Diluted EPS | โ$4.13 | โ$3.25 | โ$1.15 | โ$0.28 | โ$0.19 | โ$0.35 | โ$0.31 |
| Diluted shares | 0.01B | 0.01B | 0.03B | 0.10B | 0.10B | 0.11B | 0.10B |
| Cash flow | |||||||
| Cash from operations | โ$21.6M | โ$19.6M | โ$21.6M | โ$22.1M | โ$6.4M | $1.0M | โ$12.7M |
| Capital expenditure | $1.4M | $0.9M | $1.4M | $1.1M | $1.2M | $1.9M | $1.1M |
| Free cash flow | โ$23.0M | โ$20.5M | โ$23.1M | โ$23.2M | โ$7.5M | โ$0.8M | โ$13.8M |
| Depreciation and amortization | $1.0M | $1.1M | $1.1M | $1.4M | $1.6M | $2.5M | $3.0M |
| Stock-based compensation | $2.9M | $5.3M | $9.9M | $12.1M | $15.0M | $15.1M | $16.5M |
| Acquisitions | โ | โ | โ | โ | โ | $7.8M | โ |
| Share buybacks | โ | โ | โ | โ | โ | $1.0M | $24.0M |
| Dividends and buybacks | โ | โ | โ | โ | โ | $1.0M | $24.0M |
| Balance sheet | |||||||
| Cash and short-term investments | $15.6M | $26.3M | $56.8M | $148M | $142M | $131M | $92.6M |
| Current assets | โ | $76.4M | $199M | $189M | $175M | $154M | $119M |
| Current liabilities | โ | $11.2M | $15.7M | $24.8M | $15.9M | $20.3M | $22.9M |
| Inventory | โ | $3.2M | $9.3M | $23.8M | $13.8M | $10.2M | $10.1M |
| Property and equipment, net | $2.6M | $2.4M | $2.7M | $2.8M | $3.0M | $3.6M | $2.9M |
| Goodwill | โ | โ | โ | โ | โ | $1.8M | $1.8M |
| Intangible assets | โ | โ | โ | โ | โ | $4.7M | $3.8M |
| Total assets | โ | $79.2M | $203M | $196M | $181M | $172M | $135M |
| Total liabilities | โ | $11.8M | $20.4M | $28.2M | $16.3M | $29.5M | $29.7M |
| Shareholders' equity | โ$68.3M | โ$82.2M | $182M | $167M | $164M | $143M | $105M |
| Margins | |||||||
| Gross margin | 79.0% | 76.4% | 71.6% | 69.9% | 62.5% | 59.2% | 62.4% |
| Operating margin | โ46.6% | โ40.0% | โ38.3% | โ31.3% | โ32.0% | โ71.5% | โ48.2% |
| EBITDA margin | โ44.9% | โ38.1% | โ36.7% | โ29.8% | โ30.0% | โ67.1% | โ44.0% |
| Net margin | โ43.2% | โ34.5% | โ37.5% | โ30.5% | โ23.4% | โ63.2% | โ44.7% |
| FCF margin | โ38.4% | โ36.0% | โ32.6% | โ25.6% | โ9.0% | โ1.5% | โ19.5% |
| Returns | |||||||
| Return on capital employed | โ | โ33.5% | โ14.5% | โ16.6% | โ16.4% | โ27.2% | โ30.5% |
| Return on equity | โ | โ | โ53.1% | โ15.8% | โ11.9% | โ23.8% | โ25.5% |
| Return on assets | โ | โ24.8% | โ18.8% | โ13.9% | โ10.5% | โ20.7% | โ20.6% |
| Return on tangible equity | โ | โ | โ20.8% | โ16.5% | โ12.0% | โ26.9% | โ31.8% |
| Growth | |||||||
| Revenue growth | โ | โ5.2% | 24.2% | 28.3% | โ7.2% | โ31.3% | 22.1% |
| Share count change | โ | 9.7% | 216.1% | 196.1% | 4.3% | 3.4% | โ2.2% |
| Financial health | |||||||
| Current ratio | โ | 6.8x | 12.7x | 7.6x | 11.0x | 7.6x | 5.2x |
| Quick ratio | โ | 6.6x | 12.1x | 6.6x | 10.1x | 7.1x | 4.7x |
| Capital allocation | |||||||
| Capex / revenue | 2.4% | 1.5% | 2.0% | 1.2% | 1.4% | 3.2% | 1.5% |
| Stock comp / revenue | 4.8% | 9.4% | 14.0% | 13.3% | 17.9% | 26.1% | 23.4% |
| Quality scores | |||||||
| Piotroski F-score | โ | โ | 3.0 | 2.0 | 4.0 | 2.0 | 4.0 |
| Altman Z'' | โ | โ8.1 | 12.3 | 8.1 | 12.2 | 4.5 | 0.7 |
| Accruals ratio | โ | โ0.0% | โ3.5% | โ2.8% | โ7.1% | โ21.3% | โ12.3% |
Source: SEC EDGAR XBRL filings (CIK 0001863006). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
